Business Description
Diamond Biotechnology Co Ltd
ISIN : TW0006815004
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 1.02 | |||||
Debt-to-EBITDA | 3.04 | |||||
Interest Coverage | 8.69 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.87 | |||||
Beneish M-Score | -2.42 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.9 | |||||
3-Year EBITDA Growth Rate | 16.7 | |||||
3-Year EPS without NRI Growth Rate | 68.6 | |||||
3-Year Book Growth Rate | 14.3 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.09 | |||||
9-Day RSI | 34.59 | |||||
14-Day RSI | 40.86 | |||||
6-1 Month Momentum % | 14.12 | |||||
12-1 Month Momentum % | 64.73 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.5 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 85.52 | |||||
Days Sales Outstanding | 99.22 | |||||
Days Payable | 44.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.13 | |||||
Dividend Payout Ratio | 0.07 | |||||
Forward Dividend Yield % | 0.13 | |||||
5-Year Yield-on-Cost % | 0.13 | |||||
Shareholder Yield % | -5.26 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.01 | |||||
Operating Margin % | 10.61 | |||||
Net Margin % | 7.59 | |||||
FCF Margin % | -25.28 | |||||
ROE % | 14.33 | |||||
ROA % | 6.35 | |||||
ROIC % | 9.13 | |||||
ROC (Joel Greenblatt) % | 13.08 | |||||
ROCE % | 14.41 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 56.13 | |||||
PE Ratio without NRI | 54.48 | |||||
PEG Ratio | 41.91 | |||||
PS Ratio | 4.2 | |||||
PB Ratio | 7.58 | |||||
Price-to-Tangible-Book | 7.75 | |||||
Price-to-Operating-Cash-Flow | 69.2 | |||||
EV-to-EBIT | 44.01 | |||||
EV-to-EBITDA | 24.96 | |||||
EV-to-Revenue | 4.7 | |||||
EV-to-FCF | -18.93 | |||||
Price-to-Graham-Number | 4.33 | |||||
Earnings Yield (Greenblatt) % | 2.27 | |||||
FCF Yield % | -5.93 | |||||
Forward Rate of Return (Yacktman) % | 1.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Diamond Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 616.096 | ||
EPS (TTM) (NT$) | 1.68 | ||
Beta | 1.05 | ||
Volatility % | 99.79 | ||
14-Day RSI | 40.86 | ||
14-Day ATR (NT$) | 3.137491 | ||
20-Day SMA (NT$) | 96.685045 | ||
12-1 Month Momentum % | 64.73 | ||
52-Week Range (NT$) | 55.848247 - 148.750515 | ||
Shares Outstanding (Mil) | 27.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Diamond Biotechnology Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Diamond Biotechnology Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Diamond Biotechnology Co Ltd Frequently Asked Questions
What is Diamond Biotechnology Co Ltd(ROCO:6815)'s stock price today?
When is next earnings date of Diamond Biotechnology Co Ltd(ROCO:6815)?
Does Diamond Biotechnology Co Ltd(ROCO:6815) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |